Markets:

Overview

News

Currencies

International

Treasuries

BioRestorative Therapies, Inc. - Common Stock (NQ:BRTX)

0.3890 -0.0054 (-1.37%)

Streaming Delayed Price Updated: 3:58 PM EDT, Jun 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioRestorative Therapies, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Roth MKM Analyst Projects An Impressive Price Target of $15 Over The Next 12 Months For BioRestorative Therapies (NASDAQ: BRTX), Says “Low Valuation Undeserved”

September 18, 2023

Via ACCESSWIRE

Roth MKM Analyst Projects An Impressive Price Target Of $15 Over The Next 12 Months For BioRestorative Therapies (NASDAQ: BRTX), Says "Low Valuation Undeserved" ↗

September 14, 2023

BioRestorative Therapies Inc. (NASDAQ: BRTX) (“BioRestorative”) is a clinical-stage biotech company that is developing cell-based therapies to treat chronic lumbar disc disease and metabolic conditions...

Via Benzinga

EXCLUSIVE: Stem Cell Focused BioRestorative Ventures Into $63B Aesthetics Market Via Supply Agreement With Evolutionary Biologics ↗

September 12, 2023

BioRestorative Therapies Inc (NASDAQ: BRTX) has entered into a supply agreement with Evolutionary Biologics, a supplier of biologic-based cosmetics.

Via Benzinga

Topics Supply Chain

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 06, 2023

Via Benzinga

BioRestorative Therapies And 3 Other Stocks Under $3 Insiders Are Buying ↗

September 01, 2023

The Dow Jones closed lower by over 150 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

As America Grapples With A Deadly Opioid Epidemic, BioRestorative Therapies Is Looking To Treat Chronic Pain Without The Need For Class-A Drugs

August 30, 2023

Via ACCESSWIRE

As America Grapples With A Deadly Opioid Epidemic, BioRestorative Therapies Is Looking To Treat Chronic Pain Without The Need For Class-A Drugs ↗

August 29, 2023

Chronic back pain is a significant issue in the United States, affecting millions of individuals annually. According to experts, up to 80% of the population will experience back pain at some point.

Via Benzinga

BioRestorative Therapies Gains Additional Investor Confidence As Insider Dale Broadrick, CEO Lance Alstodt Purchase Thousands of Shares

August 02, 2023

Via ACCESSWIRE

BioRestorative Therapies Gains Additional Investor Confidence As Insider Dale Broadrick, CEO Lance Alstodt Purchase Thousands of Shares ↗

August 01, 2023

Valuations, competitive landscape and market opportunity are fundamental characteristics in evaluating investment decisions. Insider buying – the “smart money” – can also be an indicator to evaluate...

Via Benzinga

Chronic Pain Specialist Speaks At Panel On Stem Cell-Based Therapies And The Need For Spinal Care Reform - Insights From The Discussion

July 31, 2023

Via ACCESSWIRE

Over $4M Bet On Yellow Corp? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying ↗

July 31, 2023

The Dow Jones closed higher on Friday, also recording gains for the week. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and...

Via Benzinga

Chronic Pain Specialist Speaks At Panel On Stem Cell-Based Therapies And The Need For Spinal Care Reform – Insights From The Discussion ↗

July 27, 2023

Chronic back pain is a significant issue in the United States, affecting millions of individuals annually.

Via Benzinga

$5.7M Bet On This Tech Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying ↗

July 26, 2023

The Dow Jones closed higher on Tuesday, recording gains for the 12th straight session. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects....

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

July 25, 2023

On Tuesday, 56 companies set new 52-week lows.

Via Benzinga

Why Metropolitan Bank Holding Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

July 21, 2023

Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) jumped 69% to $22.59 after the company announced it reached a settlement with the SEC.

Via Benzinga

BioRestorative Therapies (NASDAQ:BRTX) Receives Landmark License From New York State

July 21, 2023

Via ACCESSWIRE

BioRestorative Therapies (NASDAQ: BRTX) Receives Landmark License From New York State ↗

July 20, 2023

BioRestorative Therapies Inc. (NASDAQ: BRTX) (“BioRestorative”), a clinical-stage company specializing in stem cell-based therapies, has announced that it has been granted a license by the New York...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 11, 2023

Via Benzinga

Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

July 11, 2023

Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares climbed 129.5% to $8.01 after gaining 9% on Monday.

Via Benzinga

Why BioRestorative Therapies (BRTX) Stock Is Getting Hammered ↗

July 11, 2023

BioRestorative Therapies Inc (NASDAQ: BRTX) shares are trading lower by 17.13% to $2.95 Tuesday morning after the company announced a $2.1 million registered direct offe

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 11, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 10, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 10, 2023

Via Benzinga

BioRestorative Therapies' Drug Candidate BRTX-100 Passes Safety Test With Flying Colors, Moves Ahead With Phase 2 And Looks To Expand Pipeline Opportunities

July 07, 2023

Via ACCESSWIRE

BioRestorative Therapies' Drug Candidate BRTX-100 Passes Safety Test With Flying Colors, Moves Ahead With Phase 2 And Looks To Expand Pipeline Opportunities ↗

July 06, 2023

BioRestorative Therapies Inc. (NASDAQ: BRTX) has received a unanimous recommendation to proceed in its Phase 2 clinical trial for chronic lumb

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 27, 2023

Via Benzinga

EXCLUSIVE: Data Monitoring Committee Allows BioRestorative's Chronic Lumbar Disc Disease Study To Continue Unchanged ↗

June 27, 2023

BioRestorative Therapies Inc (NASDAQ: BRTX) has announced that the independent Data Safety Monitoring Board (DSMB), overseeing the company's ongoing Phase 2 trial to treat chronic lumbar disc disease,...

Via Benzinga

BioResorative CEO is Featured in An Interview With SmallCaps Daily

June 26, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

June 26, 2023

Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular...

Via Benzinga

Metabolic Syndrome: The Silent Epidemic On The Rise And How BioRestorative Therapies Inc. Is Helping Fight It

June 15, 2023

Via ACCESSWIRE

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.